HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer

Dou, ZY; Qiu, CP; Zhang, X; Yao, S; Zhao, C; Wang, ZX; Chu, R; Chen, JY; Chen, ZS; Li, RR; Wang, K; Liu, PL; Liu, C; Song, K; Kong, BH

Song, K; Kong, BH (通讯作者)，Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Peoples R China.;Song, K; Kong, BH (通讯作者)，Shandong Univ, Gynecol Oncol Key Lab, Qilu Hosp, Jinan, Peoples R China.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022; 18 (3): 1188

Abstract

Ovarian cancer is the most lethal gynecological malignancy. Recurrence and chemoresistance are tough challenges leading to poor prognosis. HJURP is a ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索